SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : International Nursing Services Inc, old (NURS) new (MDIX) -- Ignore unavailable to you. Want to Upgrade?


To: Doug Fir who wrote (985)5/7/1998 1:27:00 AM
From: Mike Moran  Read Replies (1) | Respond to of 2911
 
Doug.... if biotechs and medical device companies were held to the same standard as MDIX and it's Cymedix division, there would be no public investment in biotechs or medical device companies. Yet those stock sectors thrive. Those companies have no revenues. Or, look at Synetic (SNTC). It makes plastic vessels and has a new healthcare Internet division. It's Internet technology is inferior to Cymedix. It has no Internet revenues, no product, not even a name for its Internet product. It is a year, at least, behind Cymedix. It has no patents. It's revenues and profits for the plastics are about where MDIX was/is with its staffing business.

SNTC sells for $64 and has a marketcap of $1.3 billion
MDIX sells for $.56 and .........